Sol-Gel Technologies Ltd. business relationships
Companies named in Sol-Gel Technologies Ltd.’s 20-F filed 2026-03-19, and public companies whose annual reports name Sol-Gel Technologies Ltd.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 3.5 / 10
- AI naming
- <1 / 100 Top 55% in its category
- Agent readiness
- 25 / 100
- AI adoption
- 0 / 100
Named in Sol-Gel Technologies Ltd.’s annual report 4
“Epsolay was approved for marketing by the FDA in April 2022 and was licensed to Galderma exclusively in the United” SEC filing
“The Company has a license agreement with Searchlight, and had a license agreement with Galderma, which was terminated during 2025.” SEC filing
“revenues from royalties related to our collaboration agreements with Galderma in the amounts of $1.2 million, $1.6 million, and $0.7 million,” SEC filing
“License Agreement between Sol-Gel Technologies Ltd. and Searchlight Pharma Inc. dated June 5, 2023 (incorporated by reference to Exhibit 4.22 of the Annual Report on Form 20-F filed with the Securities and Exchange Commission on March 13, 2024).” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.